PL1, Thanks for posting yet another interesting and relevant article. It appears, increasingly, there is an enormous amount of important progress to be made, in Pharmacogenomics (also known as Personalized Medicine/Theranostics.) I'm glad that DNAPrint Genomics is one of a handful of companies, that is pioneering this field.
P.S., I currently own 198,411,787 shares of DNAG. (15.3% of outstanding shares.)
:-)
Daniel Gannon
Portland, Oregon, USA